The largest database of trusted experimental protocols

125 protocols using discovery ste

1

Fasting PET/CT Protocol for 18F-FDG Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the patients fasted for at least 6 hours, and blood glucose was < 200 mg/dL at the time of 18F-FDG injection. PET/CT without intravenous or oral contrast was performed with dedicated PET/CT scanners (Discovery LS or Discovery STE, GE Healthcare [Chicago, IL, USA] at Samsung Medical Center; Biograph DUO or Biograph Truepoint, Siemens Healthcare [Erlangen, Germany] at Seoul St. Mary's Hospital; Biograph Truepoint 40 or mCT 40, Siemens Healthcare at Seoul National University Hospital; Reveal RT-HiREZ 6-slice CT, CTI Molecular Imaging or Discovery STE, GE Healthcare at Kyungpook National University Hospital). At 60 minutes after injecting 225–550 MBq 18F-FDG, CT images were obtained from the skull base to the proximal thigh or the whole body using helical CTs (120–140 kVp, 25–170 mAs), adjusted for body thickness. PET followed immediately over the same body region at 1–4 minutes per frame in two-dimensional or three-dimensional mode. Attenuation-corrected PET images were reconstructed using CT data and an iterative method (2 or 4 iterations).
+ Open protocol
+ Expand
2

FDG-PET/CT Imaging Protocol for Metabolic Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients fasted for at least six hours and blood glucose level was < 200 mg/dL at the time of PET/CT. Whole-body PET and CT images were acquired 60 min after injection of 5.0 MBq/kg FDG without intravenous or oral contrast on a Discovery LS, a Discovery STE, or a Discovery MI DR PET/CT scanner (GE Healthcare, Milwaukee, WI). Continuous spiral CT was performed with an eight-slice helical CT (140 keV, 40–120 mA, Discovery LS) or 16-slice helical CT (140 keV, 30–170 mA, Discovery STE; 120 keV, 30–100 mA, Discovery MI DR). An emission scan was performed from head to thigh for 4 min per frame in two-dimensional mode (Discovery LS), 2.5 min per frame in three-dimensional mode (Discovery STE), or 2 min per frame in three-dimensional mode (Discovery MI DR). PET images were reconstructed using CT for attenuation correction using the ordered-subsets expectation maximization algorithm with 28 subsets and 2 iterations (matrix 128 × 128, voxel size 4.3 × 4.3 × 3.9 mm, Discovery LS), ordered-subsets expectation maximization algorithm with 20 subsets and two iterations (matrix 128 × 128, voxel size 3.9 × 3.9 × 3.3 mm, Discovery STE), or ordered-subsets expectation maximization algorithm with 18 subsets and four iterations (matrix 192 × 192, voxel size 3.9 × 3.9 × 3.3 mm, Discovery MI DR). The SUV was calculated by adjusting for administered FDG dose and patient body weight.
+ Open protocol
+ Expand
3

FDG PET/CT Imaging Protocol for Tumor Size

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor size was measured by magnetic resonance imaging. If tumor size was reported in three axes, the largest diameter was considered to be the tumor size.
All 18F-FDG PET/CTs were performed with dedicated PET/CT scanners (Discovery STe, GE Healthcare at Kyungpook National University Chilgok Hospital and Daegu Catholic University School of Medicine, Discovery ST/Discovery VCT, GE Healthcare at Yeungnam University Medical Center). All patients fasted for at least 6 h before the PET/CT. Blood glucose levels were measured and were required to be less than 150 mg/dL. A dose of approximately 5.5 MBq/kg of FDG was intravenously administered. At all institutions, PET/CT was performed from the thigh to the head, about 60 min after intravenous administration of FDG. Whole-body CT was performed without contrast enhancement using the following standard protocols: 140 kVp, 30 to 170 mAs adjusted to the patient’s body weight, and 3-mm slice thickness (Discovery STe); 100–120 kVp, 100–120 mAs, and 3.75-mm slice thickness (Discovery ST and Discovery VCT). An emission scan was performed in 3D mode after the CT scan. The acquisition time was 3 min per bed position. PET images were reconstructed by an iterative ordered subset expectation maximization algorithm using CT images for attenuation correction (Discovery STe, 4 iterations, 8 subsets; Discovery ST/Discovery VCT, 2 iterations, 8 subsets).
+ Open protocol
+ Expand
4

PET/CT Imaging Protocol for FDG Uptake

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients were recommended to fast for at least 4 h before the FDG-PET/CT scan (4.07-5.55 MBq/kg). Blood glucose levels were maintained at less than 11 mmol/L. A whole-body scan was acquired at 60 ± 10 min after intravenous injection of 18F-FDG using an integrated PET/CT scanner (Discovery STE; General Electric Medical Systems, Milwaukee WI, USA). First, low-dose CT images were performed, with parameters as follows: 140 kV, 120 mA, transaxial field of view (FOV) of 70 cm, pitch of 1.75, rotation time of 0.8 s, and slice thickness of 3.75 mm, followed by PET images, with 2-3 min per bed position and 7-8 bed positions per patient.
+ Open protocol
+ Expand
5

Standardized PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Because we accrued patients over a period of 14 y, the PET/CT scans had been obtained with multiple scanner types. However, patient preparation and image acquisition protocols were comparable over the years. All scans were acquired using PET/CT cameras, including Discovery LS, Discovery ST, and Discovery STE (all GE Healthcare) or Biograph LSO-16 (Siemens Medical Solutions). No information on the scanner system was available for 22% of the patients. Patients were instructed to fast for at least 6 h before 18F-FDG administration, and blood glucose levels were required to be less than 200 mg/dL at the time of injection. The scans were acquired from the upper thighs to the base of the skull (5–7 bed positions) 60–90 min after injection of about 400 MBq of 18F-FDG. CT was performed for attenuation correction and anatomic localization. Immediately after the CT image acquisition, PET data were acquired for 3–5 min per bed position. The attenuation-corrected PET data were reconstructed using an ordered-subset expectation maximization iterative reconstruction.
+ Open protocol
+ Expand
6

Brain Glucose Metabolism PET/CT Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects fasted for at least 4 hours before the procedure and their blood glucose was <160 mg/dL at the time of the scan. Subjects were injected with 185 to 370 MBq of 18F-FDG, and followed by 30 minutes resting in a quiet, dimly lit room. Brain PET/CT scans were acquired using a dedicated PET/CT scanner (Discovery STE, GE Healthcare). Emission scans were started 30 minutes after injection and data were acquired for 10 minutes in the 3-dimensional mode. Images were reconstructed using an ordered subset expectation maximization (OSEM) algorithm. Attenuation correction was based on the CT scan and scatter correction was performed using standard software as supplied by the scanner manufacturer.
+ Open protocol
+ Expand
7

FDG PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were scanned using a PET/CT scanner (PET/CT-16 slice, Discovery STE; GE Medical System, Milwaukee, WI, USA). The patients were requested to fast for at least 4 hours before the administration of (18F)-FDG, and FDG PET/CT imaging was conducted approximately 60 minutes after the administration of 370 MBq of 18F-FDG. Thus, FDG uptake was determined in order to calculate the standardized uptake value (SUV). The maximum SUV (SUVmax) was confirmed through consensus between two nuclear medicine physicians.
In addition, the CT-based gross tumor volume was obtained for all patients as previously described9 .
+ Open protocol
+ Expand
8

Delayed FDG PET-CT Imaging of Lung Nodules

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were asked to fast for at least 4 h before FDG PET-CT imaging. Imaging was performed with a PET-CT scanner (Discovery STE, GE Medical Systems, Milwaukee, WI, United States). Whole-body FDG PET-CT images were acquired approximately 45 min after intravenous injection of 370 MBq (10 mCi) of FDG. Delayed FDG PET-CT images were obtained approximately 70 min after FDG injection (33 (link)–35 (link)). In this study, however, we only adopted the delayed FDG PET-CT images for further preprocessing and input to the deep learning models. PET emission images were acquired after CT scans at 2 min per field of view in the three-dimensional acquisition mode. The CT images were reconstructed onto a 512 × 512 matrix with a section thickness of 3.75 mm, reconstructed onto a 128 × 128 matrix, and converted into 511 keV equivalent attenuation factors for attenuation correction of the corresponding PET emission images. The maximum SUVmax of lung nodules on early and delayed FDG PET-CT images were measured.
+ Open protocol
+ Expand
9

Standardized 18F-FDG PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients underwent clinical routine 18 F-FDG PET/CT. After a fasting time of at least 6 h, a single injection in bolus of 18 F-FDG (mean adjusted dose 3.5–4.5 MBq/kg) was administered. Patients were scanned after 60 min from 18 F-FDG administration (uptake time), after hydration (500 mL water) and after voiding the bladder. Images were acquired on cross-calibrated GE Discovery MI, Discovery STE, Discovery 710 (General Electric, Milwaukee, WI, USA), acquisition time was 2 min per bed position. In summary, the acquisition protocol was performed according to the European Association of Nuclear Medicine (EANM) procedure guidelines [15 (link)].
+ Open protocol
+ Expand
10

Standardized PET/CT and CE-CT Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
All PET/CT and CE-CT examinations followed basic study protocols. For PET/CT, patients fasted for at least four hours, FDG dosage was body-weight adjusted, the uptake time was standardized to 60 minutes in supine position, a non-enhanced CT scan was performed and used for attenuation correction, and data was acquired with arms overhead whenever possible. Blood glucose levels <12 mmol/l were accepted. Body weight, height, and blood glucose level were measured prior to imaging. Five different types of PET/CT scanners were used throughout the study period, i.e. Discovery STE, Discovery LS, Discovery RX, Discovery MI, and Discovery 690 (all GE Healthcare, Waukesha, WI). To compensate for differences in the sensitivity of the different PET/CT scanner generations, we measured the metabolic activity in the mediastinal blood pool and in the liver tissue for reference.
For CE-CT of the abdomen, 80 ml iodinated contrast material (Visipaque® 320, GE Healthcare) were injected, timed for imaging at the portal venous phase with a tube voltage of 120 kV and a tube current–time product of 100–320 mAs. If patients had a recent CE-CT of the region of interest prior to the PET/CT, the CE-CT was not repeated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!